ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences
ValConnect Innovation Day Princeton brought Bayer, GSK, Cardinal Health, Transcat & Hansa Biopharma together to explore AI & Smart GxP™ in life sciences.
Welcome to the ValGenesis blog, your resource for timely insights from industry-leading experts on the trends, best practices, and new technologies impacting the life sciences.
Apr 20, 2023 9:52:54 AM | This post examines the crucial impact quality culture has on individuals, organizations, and processes; it offers tips for improving it in your company.
This post examines the crucial impact quality culture has on individuals, organizations, and processes; it offers tips for improving it in your company.
An efficient control strategy will ensure your processes performs always as expected. In this blog post we described the steps to design one.
This a story about how we helped a company with their biosimilarity assessments and to avoid massive time-to-market delay!
Today we want to take a fresh look into comparability for post-approval changes. How? We're thinking of a unique multiparametric approach.
This time we tell you how we helped a company finding a root-cause in a Filter Clogging and how we solved it.
A story about this time we helped a company in the Post-Approval Change Management of a Legacy Product using a Retrospective QbD methodology.
In this blog post we explore the topic of minimising the subjectivity in Risk Assessments through Digitalisation of processes.
This blog post goes over the key aspects of developing solid comparability studies on early development stages.
Many medical device companies have struggled with implementing a risk management process that results in risk being mitigated to the level of AFAP.
The ICH released a draft version of the new ICH Q14 Guideline last March. This blog post will give you an overview of its key implementation aspects.
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
An important, and sometimes challenging, step in every product lifecycle is the point when it gets its premarket or a postmarket regulatory approval by the FDA. Luckily, through a combination of good practices for Benefit-Risk Assessment and technology, this has become much easier.
In this blog post, we’ll go through some concepts on Knowledge Management and the starting points for its implementation.
A light story about how ValGenesis joining on a quest to optimize a stage in a process, how did we do it and what came out of it.
Quality Risk Management
Finding the Root Cause in mAB Production: a ValGenesis Story
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
Written by
Sofia Santos
Tech Transfer & Process Scale-up
How to Accelerate Process Scale-Up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Written by
Sofia Santos
Cleaning Validation
Risk-Based Cleaning Validation: A Lifecycle Approach
Explore the evolution of pharmaceutical cleaning validation from compliance-focused practices to a risk-based, lifecycle-driven approach.
Written by
Kenneth Pierce
CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.
ValConnect Innovation Day Princeton brought Bayer, GSK, Cardinal Health, Transcat & Hansa Biopharma together to explore AI & Smart GxP™ in life sciences.
Previously
Catalent's Journey of Continuous Improvement for CSV Excellence
Are You Aligned with FDA's Computer Software Assurance Methodology?
Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.
Explore the complexities of cleaning validation limits, including HBEL/MACO, 10 ppm, and visually clean to ensure patient safety and product quality.
Previously
Change Impact Assessments in ValGenesis iClean™: A Framework for Consistency
Unlocking Operational Capacity with Fully Digitalized Cleaning Validation
Waves of new technology and thinking — IoT, AR, cloud, Agile — are transforming the very foundation of validation processes. Learn how to leverage them in a Pharma 4.0 world.
Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.